A citation-based method for searching scientific literature

Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
Times Cited: 67



H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
Times Cited: 1045




List of shared articles



Times cited

Progresses Toward Precision Medicine in RET-altered Solid Tumors.
Carmen Belli, Santosh Anand, Justin F Gainor, Frederique Penault-Llorca, Vivek Subbiah, Alexander Drilon, Fabrice Andrè, Giuseppe Curigliano. Clin Cancer Res 2020
14

Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.
Maran Ilanchezhian, Sophia Khan, Christian Okafor, John Glod, Jaydira Del Rivero. Horm Metab Res 2020
4

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
C Belli, F Penault-Llorca, M Ladanyi, N Normanno, J-Y Scoazec, L Lacroix, J S Reis-Filho, V Subbiah, J F Gainor, V Endris,[...]. Ann Oncol 2021
29

Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
Ramona Dadu, Mimi N Hu, Elizabeth G Grubbs, Robert F Gagel. Recent Results Cancer Res 2015
10

Structure and physiology of the RET receptor tyrosine kinase.
Carlos F Ibáñez. Cold Spring Harb Perspect Biol 2013
99

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
137


Thyroid C-Cell Biology and Oncogenic Transformation.
Gilbert J Cote, Elizabeth G Grubbs, Marie-Claude Hofmann. Recent Results Cancer Res 2015
28

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
0

The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
William Grey, Rosaline Hulse, Anna Yakovleva, Dilyana Genkova, Benjamin Whitelaw, Ellen Solomon, Salvador J Diaz-Cano, Louise Izatt. Endocr Pathol 2017
1

Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
Renuka Raman, Jacques A Villefranc, Timothy M Ullmann, Jessica Thiesmeyer, Viviana Anelli, Jun Yao, James R Hurley, Chantal Pauli, Rohan Bareja, Kenneth Wha Eng,[...]. J Exp Med 2022
0